How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Healthcare and Pharmaceuticals · Forecast 2027–2033
Localization for Breast Surgery Market
- By Localization Technique: Wire-Guided Localization (WGL), Radioactive Seed Localization (RSL), Magnetic Seed Localization, Intraoperative Ultrasound Localization, Carbon Tattoo Localization
- By Surgical Procedure Type: Breast-Conserving Surgery (Lumpectomy), Mastectomy, Oncoplastic Surgery, Sentinel Lymph Node Biopsy, Axillary Lymph Node Dissection
- By Imaging Modality for Localization: Mammography-Guided Localization, Ultrasound-Guided Localization, MRI-Guided Localization, Tomosynthesis-Guided Localization
- By End User: Hospitals, Specialty Breast Care Centers, Ambulatory Surgical Centers, Diagnostic Imaging Centers
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Wire-Guided Localization (WGL) leads By Localization Technique at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 16 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 279 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.166 →
- 11 Company Profiles 16 players: SWOT & benchmarking p.174 →
Full report · locked preview
Everything inside the Localization for Breast Surgery Market report
A complete, evidence-based study - 11 chapters and 117 sections covering market size, segmentation across 4 axes, regional analysis and 16 company profiles, forecast to 2033.
Segmentation covered
Localization Technique 5
Surgical Procedure Type 5
Imaging Modality for Localization 4
End User 4
Companies profiled
Hologic Inc.
Becton
Dickinson and Company (BD)
Mammotome (Devicor Medical Products
Inc.)
Cianna Medical Inc.
Hologic
Inc. (SenoRx)
C.R. Bard
Inc. (now part of BD)
MammoSite (Hologic)
Seno Medical Instruments Inc.
+4 more
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
16 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Hologic Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Becton
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Dickinson and Company (BD)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Mammotome (Devicor Medical Products
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Inc.)
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Cianna Medical Inc.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →Hologic
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.191 →Inc. (SenoRx)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →C.R. Bard
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Inc. (now part of BD)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →MammoSite (Hologic)
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Seno Medical Instruments Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Galil Medical (acquired by BTG plc)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Merit Medical Systems Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →SenoRx Inc.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Inc. (Acessa Health)
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.245 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$5,337M by 2033 · 10.1% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Wire-Guided Localization (WGL)39.0
- Radioactive Seed Localization (RSL)17.8
- Magnetic Seed Localization14.0
- Intraoperative Ultrasound Localization18.7
- Carbon Tattoo Localization10.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$814.1M → $1,799M · 10.4%
Europe$567.4M → $1,275M · 10.6%
Asia Pacific$518.0M → $1,162M · 10.6%
Latin America$320.7M → $750.2M · 11.2%
Middle East and Africa$246.7M → $495.3M · 9.1%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →10.082026
10.092027
10.112028
10.112029
10.132030
10.152031
10.162032
10.162033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Hologic Inc.19.4
- Becton17.5
- Dickinson and Company (BD)11.7
- Mammotome (Devicor Medical Products4.3
- Inc.)10.4
- Cianna Medical Inc.8.8
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Localization Technique13.2%
Surgical Procedure Type23.4%
Imaging Modality for Localization34.5%
End User28.9%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America32.8
- Europe23.3
- Asia Pacific21.2
- Latin America13.7
- Middle East and Africa9.0
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Hologic Inc. | 89 | 89 | 81 | 98 | 84 | 80 | 87 |
| Becton | 68 | 80 | 81 | 90 | 77 | 86 | 80 |
| Dickinson and Company (BD) | 67 | 82 | 81 | 69 | 66 | 83 | 75 |
| Mammotome (Devicor Medical Products | 61 | 57 | 74 | 60 | 61 | 60 | 62 |
| Inc.) | 66 | 69 | 52 | 77 | 63 | 58 | 64 |
| Cianna Medical Inc. | 46 | 71 | 55 | 46 | 64 | 63 | 58 |
| Hologic | 60 | 43 | 45 | 58 | 47 | 66 | 53 |
| Inc. (SenoRx) | 59 | 44 | 45 | 57 | 52 | 35 | 49 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Hologic Inc.
- Becton
- Dickinson and Company (BD)
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Hologic Inc. | ✓ | ✓ | ✓ | ✓ | ✓ | ◐ |
| Becton | ✓ | ◐ | ✓ | ✓ | ◐ | ✓ |
| Dickinson and Company (BD) | ◐ | ✓ | ✓ | ✓ | − | ✓ |
| Mammotome (Devicor Medical Products | − | − | ◐ | ◐ | − | ✓ |
| Inc.) | ◐ | − | ◐ | ✓ | − | ◐ |
| Cianna Medical Inc. | − | ◐ | ◐ | − | ✓ | ◐ |
| Hologic | ◐ | − | ◐ | ◐ | − | ◐ |
| Inc. (SenoRx) | ◐ | − | − | − | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1Hologic Inc.87
2Becton80
3Dickinson and Company (BD)75
4Inc.)64
5Mammotome (Devicor Medical Products62
6Cianna Medical Inc.58
7Hologic53
8Inc. (SenoRx)49
Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Hologic Inc.Becton
Challenger1
Strong scale, closing on the leaders.
Dickinson and Company (BD)
Contender3
Focused players with pockets of strength.
Mammotome (Devicor Medical ProductsInc.)Cianna Medical Inc.
Niche2
Specialists in a single segment or region.
HologicInc. (SenoRx)
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Localization Technique in North America, then scale across Localization for Breast Surgery Market — a $55M beachhead inside a $991M market.
Beachhead (SOM)$55Mobtainable near-term
Serviceable (SAM)$378Mreachable market
Primary motionDirect + partner-ledgo-to-market
Time to scale4 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion88 fit
Wire-Guided Localization (WGL)
Best fit — highest urgency & budget in Localization Technique.
Economic buyer77 fit
Radioactive Seed Localization (RSL)
Strong fit — clear ROI and a fast path to value.
End user65 fit
Magnetic Seed Localization
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Localization Technique in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Surgical Procedure Type & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Imaging Modality for Localization
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales44%
Partner / channel29%
Digital / self-serve21%
Marketplaces7%
Positioning & messaging
§GTM 2 · p.194 →For Localization Technique leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Localization for Breast Surgery Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified38%
Sales qualified21%
Evaluation13%
Closed-won7%
$17.3KCAC
$86KLTV
5.0:1LTV : CAC
< 4 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Localization for Breast Surgery Market is a high-growth opportunity — $6.89B by 2033, compounding at 11.6%.
TAM · 2025$2.87Btoday
TAM · 2033$6.89Bforecast
CAGR11.6%2027–2033
Cumulative$41.6Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.89BTotal addressable market
SAM$2.36BServiceable available market
SOM$454MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →11.6% CAGR
Demand compounds through 2033, outpacing GDP across Localization Technique.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Localization Technique moving from early to mainstream — durable secular demand.
Consolidation upside
16+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.89BLarge & growingTAM by 2033 at 11.6% CAGR
$2.36BServiceable nowreachable with today’s model
$454MBeachhead winobtainable near-term share
16+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$5.37BBear7.5% CAGR
$6.89BBase11.6% CAGR
$8.82BBull15.3% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Surgical Procedure Type optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Localization for Breast Surgery Market — a $6.49B market by 2033. Plan: grow share from 8.7% to 14.6%.
Market size · 2033$6.49Btotal addressable
Market CAGR9.4%2027–2033
Target share14.6%from 8.7% today
Revenue ambition$947Mby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 8.7% | 14.6% | At risk |
| Revenue | $532M | $947M | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 36.3% | 42.2% | On track |
| Customer retention | 85.8% | 93.5% | Ahead |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Localization Technique
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Surgical Procedure Type capability
A defensible second engine — invest in Surgical Procedure Type to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Localization Technique share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Surgical Procedure Type
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $108M capacity & capability investment
- Greenlight bolt-on M&A in Surgical Procedure Type
- Authorise North America expansion plan
- Fund R&D program for Localization Technique leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownBehind
- Competitive share lossAt risk
- Input-cost & supply riskOn track
- Regulatory / policy changeOn track
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Localization for Breast Surgery Market conversation — a $7.69B market you can size, segment and defend in minutes.
Market size · 2033$7.69Btotal opportunity
Growth6.6%CAGR to 2033
Addressable buyers1,513+accounts in scope
Typical ROI5.1×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Localization Technique
Goal Grow share in Localization Technique
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →5.1×return on cost, year one
< 4 mopayback period
$99K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
16+players profiled in this market
Coverage includes
Hologic Inc.BectonDickinson and Company (BD)Mammotome (Devicor Medical ProductsInc.)Cianna Medical Inc.HologicInc. (SenoRx)+8 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Localization for Breast Surgery Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Localization for Breast Surgery Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Healthcare and Pharmaceuticals · scroll →Anti-Dermatomycosis Treatment Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportNext-Generation Drug-Eluting Stent Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportAnti Depression Drugs Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportRFID Blood Monitoring System Market
Market size, share, segmentation and regional forecast.
$757M market · 2025 base year
View reportSmall Joint Replacement Market
Market size, share, segmentation and regional forecast.
$2.5B market · 2025 base year
View reportAntidepressant Medication Market
Market size, share, segmentation and regional forecast.
$797M market · 2025 base year
View reportSilicone Breast Implants Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportHip Orthoses Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportInterspinous Spacers Market
Market size, share, segmentation and regional forecast.
$1.6B market · 2025 base year
View reportAnti-decubitus Mattresses Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportHandheld Bladder Scanners Market
Market size, share, segmentation and regional forecast.
$4.4B market · 2025 base year
View reportAnti-decubitus Inflatable Cushion Market
Market size, share, segmentation and regional forecast.
$5.4B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.